Eva Feldman on advances in understanding ALS

FromThe Lancet Neurology in conversation with

Start listening View podcast show

Eva Feldman on advances in understanding ALS

FromThe Lancet Neurology in conversation with

ratings:

Length:

23 minutes

Released:

Apr 13, 2022

Format:

Podcast episode

Description

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.

Released:

Apr 13, 2022

Format:

Podcast episode

Titles in the series (100)

Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Neurology: December 08, 2008 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: March 16, 2009 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: July 14, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: March 14, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: December 17, 2007 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: January 22, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: June 16, 2008 by The Lancet Neurology in conversation with
16 min listen
The Lancet Neurology: October 12, 2009 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: October 13, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: February 18, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: August 11, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: November 10, 2008 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: April 18, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: September 20, 2010 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: February 21, 2011 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: September 15, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: December 14, 2009 by The Lancet Neurology in conversation with
13 min listen
The Lancet Neurology: August 15, 2011 by The Lancet Neurology in conversation with
15 min listen
The Lancet Neurology: June 15, 2009 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: May 19, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: January 19, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: June 17, 2010 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: August 16, 2010 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: December 13, 2010 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: January 19, 2011 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: August 19, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: July 13, 2012 by The Lancet Neurology in conversation with
11 min listen
The Lancet Neurology: September 08, 2009 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: May 19, 2010 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: April 15, 2009 by The Lancet Neurology in conversation with
7 min listen

More Episodes from The Lancet Neurology in conversation with

Skip carousel

Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy by The Lancet Neurology in conversation with
23 min listen
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system by The Lancet Neurology in conversation with
25 min listen
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders by The Lancet Neurology in conversation with
12 min listen
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy by The Lancet Neurology in conversation with
22 min listen
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury by The Lancet Neurology in conversation with
18 min listen
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage by The Lancet Neurology in conversation with
24 min listen
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations by The Lancet Neurology in conversation with
27 min listen
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis by The Lancet Neurology in conversation with
15 min listen
William Jagust on amyloid β and cognition by The Lancet Neurology in conversation with
14 min listen
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury by The Lancet Neurology in conversation with
15 min listen
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases by The Lancet Neurology in conversation with
17 min listen
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma by The Lancet Neurology in conversation with
19 min listen
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation by The Lancet Neurology in conversation with
15 min listen
Kerstin Hellwig on family planning considerations in MS by The Lancet Neurology in conversation with
14 min listen
Geraldine Dawson on advances and in the prediction of autism during infancy by The Lancet Neurology in conversation with
25 min listen
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke by The Lancet Neurology in conversation with
9 min listen
Beau Ances on amyloid biomarkers in Alzheimer’s by The Lancet Neurology in conversation with
12 min listen
Axel Petzold on the diagnosis and classification of optic neuritis by The Lancet Neurology in conversation with
20 min listen
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery by The Lancet Neurology in conversation with
15 min listen
Jerome Siegel on sleep habits by The Lancet Neurology in conversation with
44 min listen
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy by The Lancet Neurology in conversation with
17 min listen
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy by The Lancet Neurology in conversation with
23 min listen
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies by The Lancet Neurology in conversation with
19 min listen
Mark Hallett on functional neurological disorder by The Lancet Neurology in conversation with
9 min listen
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's by The Lancet Neurology in conversation with
27 min listen
John Collinge on a treatment for CJD by The Lancet Neurology in conversation with
15 min listen
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2 by The Lancet Neurology in conversation with
8 min listen
Giuseppe Citerio on frailty and TBI by The Lancet Neurology in conversation with
10 min listen
Alberto Costa on memantine in adolescents and young adults with Down syndrome by The Lancet Neurology in conversation with
15 min listen
Olivier Rascol on amantadine for patients with movement disorders by The Lancet Neurology in conversation with
28 min listen

Related podcast episodes

Skip carousel

Ep. 74: EBV in the pathogenesis of multiple sclerosis: Moderator: Tamuna Akhvlediani (Tbilisi, Georgia) Guest: Johann Sellner (Mistelbach, Austria) In this week’s podcast hosted by Dr. Tamuna Akhvlediani, Prof. Johann Sellner discusses the connection between Epstein-Barr virus (EBV) and multiple sclerosis (MS). They explore the immune-mediated nature of MS, focusing on the impact of EBV and recent studies linking its infection to MS development. The episode delves into the controversies, hypotheses, and potential therapies related to EBV and MS, concluding with information on ongoing clinical trials and the influence of existing MS treatments on EBV. by eanCast: Weekly Neurology
14 min listen
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease: Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease by Neurology Today in 5
5 min listen
July 22 2014 Issue: Traumatic brain injury and risk of dementia in older veterans by Neurology® Podcast
31 min listen
Traumatic head injury due to child mistreatment: This podcast reviews an approach to traumatic head injury due to child mistreatment. This episode will discuss relevant biomechanics, pathophysiology, features on history, physical examination findings, investigations and approach to management. This... by PedsCases: Pediatric Education Online
18 min listen
May 8 2012 Issue: A case of necrotizing myopathy with proximal weakness and cardiomyopathy by Neurology® Podcast
26 min listen
Kenneth Schaffner, “Behaving: What’s Genetic, What’s Not, and Why Should We Care?” (Oxford UP, 2016): In the genes vs. environment debate, it is widely accepted that what we do, who we are, and what mental illnesses we are at risk for result from a complex combination of both factors. Just how complex is revealed in Behaving: What’s Genetic, by New Books in Philosophy
67 min listen
May 22 2012 Issue: Nav1.7-related small fiber neuropathy: Impaired slow-inactivation and neuronal hyperexcitability by Neurology® Podcast
22 min listen
Maple Syrup Urine Disease: This podcast will provide listeners with an understanding of Maple Syrup Urine Disease, its clinical signs and symptoms, and management. This podcast was developed by fourth year medical student Angela Messer in collaboration with Dr. Shailly Jain, an... by PedsCases: Pediatric Education Online
15 min listen
JEM June 2017 Podcast Summary: Podcast summary of articles from the June 2017 edition of Journal of Emergency Medicine from the American Academy of Emergency Medicine. Topics include epinephrine in cardiac arrest, pediatric blunt chest trauma, LuCUS protocol for congestive... by AAEM: The Journal of Emergency Medicine Audio Summary
54 min listen
April 10 2012 Issue: The long-term risk of developing epilepsy after febrile seizures: A prospective cohort study by Neurology® Podcast
19 min listen
Episode 25 - Autism Controversies, with Dr. Manuel Casanova by Autism Confidential
38 min listen
An Updated Round Table Discussion on FND: Sharing a Diagnosis and Treatment: In the last episode of our three-part series, Prof. Jon Stone talks with Drs. Selma Aybek, David Perez, and Sarah Lidstone about diagnosis and treatment for FND. Associated Links: FND Society at FND guide for patients at FND Hope at ... by Neurology® Podcast
22 min listen
May 29 2012 Issue: Cognitive effects of one season of head impacts in a cohort of collegiate contact sports athletes by Neurology® Podcast
23 min listen
JEM July 2017 Podcast Summary: Podcast summary of articles from the July 2017 edition of Journal of Emergency Medicine from the American Academy of Emergency Medicine. Topics include ketamine versus ketamine / propofol for pediatric sedation, carotid ultrasound, intranasal... by AAEM: The Journal of Emergency Medicine Audio Summary
50 min listen
Elinor Karlsson, PhD: Genetic testing from a scientist's perspective: Elinor Karlsson, Ph.D., is the director of the Vetebrate Genomics Group at the Broad Institute of MIT and Harvard and (incidentally) my boss. She has a deep knowledge about both population genetics and what we call "complex trait genomics," or the geneti... by The Functional Breeding Podcast
72 min listen
Episode 287 - Epigenetics and Neurodevelopment Symposium by Neuroscientists Talk Shop
48 min listen
Contemporary Management of HIV 2021: Frontiers in HIV Prevention, Part 2—Audio Recap: Are you abreast of what is in the pipeline for HIV prevention? Listen to expert discussion by Joseph J. Eron, Jr., MD, on 4 investigational agents for HIV prevention. by CCO Infectious Disease Podcast
16 min listen
Sport Related Concussion: This podcast explores the epidemiology, pathophysiology, diagnosis, and management of sports related concussion in children. It is the first in a two-part series on the topic (part two discusses post-concussive syndrome). The podcast was developed by... by PedsCases: Pediatric Education Online
16 min listen
Hypoxic Ischemic Encephalopathy: This podcast gives an overview of the risk factors, signs and symptoms, management and prognosis of hypoxic ischemic encephalopathy (HIE). It was developed by Carina Lauzon, a third-year medical student at the University of Alberta, and Dr.... by PedsCases: Pediatric Education Online
21 min listen
SCCM Pod-506 PCCM: Exploring Adverse Events in Pediatric Apnea: SCCM Pod-506 PCCM: Exploring Adverse Events in Pediatric Apnea by SCCM Podcast
31 min listen
Kenneth Schaffner, “Behaving: What’s Genetic, What’s Not, and Why Should We Care?” (Oxford UP, 2016): In the genes vs. environment debate, it is widely accepted that what we do, who we are, and what mental illnesses we are at risk for result from a complex combination of both factors. Just how complex is revealed in Behaving: What’s Genetic, by New Books in Psychology
66 min listen
Turning anemones into coral, and the future of psychiatric drugs: Why scientists are trying to make anemones act like corals, and why it’s so hard to make pharmaceuticals for brain diseases by Science Magazine Podcast
39 min listen
January 27 2015 Issue: The spectrum of acute encephalitis: Causes, management and predictors of outcome by Neurology® Podcast
19 min listen
NEJM Interview: Dr. Evan E. Eichler on genetic variation, comparative genomics, and the diagnosis of disease. by NEJM Interviews
8 min listen
August 11 2015 Issue: CIDP diagnostic pit-falls and perception of treatment benefits by Neurology® Podcast
22 min listen
Molecular Mechanisms of Depression with Dr. Lisa Monteggia: On this episode of Brian Matters, Anthony and Dr. Lisa Monteggia (Professor, UT Southwestern Medical Center) talked about depression and the molecular mechanisms underlying the efficacy of antidepressants. They also talked about Lisa's work... by Brain Matters
41 min listen
July 14 2015 Issue: Early EEG contributes to multimodal outcome prediction of postanoxic coma by Neurology® Podcast
28 min listen
Enthesitis-Related Arthritis (ERA): This podcast on an approach to enthesitis-related arthritis (ERA) covers classification, epidemiology, pathogenesis, clinical presentation, investigation and management. It was developed by Vivian Szeto, a medical student at the University of... by PedsCases: Pediatric Education Online
19 min listen
Extracellular Examination – Lesley Cheng Sim, PhD, Research Officer, Biochemistry, at La Trobe University – Can Extracellular Vesicles be the Key to Recognizing Early Stage Diseases?: Lesley Cheng Sim, Ph.D., Research Officer, Biochemistry, at La Trobe University, discusses extracellular vesicles (EVs) and her work as a Molecular Biologist. Lesley received her Ph.D. from Monash University in 2008; she is a postdoctoral researcher.... by Finding Genius Podcast
27 min listen
Behavioural & Biological Divergence in Monozygotic Twins Discordant for Autism - Dr Lynnea Myers by Association for Child and Adolescent Mental Health (ACAMH)
17 min listen

Discover this podcast and so much more

Eva Feldman on advances in understanding ALS

Eva Feldman on advances in understanding ALS

Description

Titles in the series (100)

More Episodes from The Lancet Neurology in conversation with

Related podcast episodes